Evidence map›Paper›PMID 18775748›Full record

ArticleJournal of neuroscience methods2008

Transient silencing of synaptic transmitter release from specific neuronal types by recombinant tetanus toxin light chain fused to antibody variable region.

Tomoko Kobayashi, Nobuyuki Kai, Kenta Kobayashi, Tomonori Fujiwara, Kimio Akagawa, Masanori Onda, Kazuto Kobayashi

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience methods, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Selective Neural Pathway Targeting by Using Lentiviral Vectors.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Remote control of neuronal signaling.Pharmacological reviews · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Tomoko KobayashiDepartment of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan.
Nobuyuki Kai
Kenta Kobayashi
Tomonori Fujiwara
Kimio Akagawa
Masanori Onda
Kazuto Kobayashi
Fukushima Medical University · JPNational Institutes of Health · USKyorin University · JP

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

We developed a novel strategy for conditional silencing of synaptic transmission in specific neuronal types in transgenic animals. We generated a recombinant protein termed immuno-tetanus toxin (ITet), which contains a monoclonal antibody variable region for human interleukin-2 receptor alpha-subunit (IL-2Ralpha) fused to tetanus toxin light chain. ITet was designed to transiently suppress transmitter release from target neurons genetically engineered to express human IL-2Ralpha via proteolytic cleavage of vesicle-associated membrane protein-2 (VAMP-2). The in vivo actions of ITet were investigated by using mutant mice that express IL-2Ralpha in striatal neurons under the control of the gene encoding dopamine D(2) receptor. Unilateral ITet injection into the striatum induced rotational behavior in the mutant mice and the rotations gradually reversed to the normal level. The behavioral alteration was accompanied by a transient decrease in the striatal VAMP-2 level and depolarization-evoked transmitter release in synaptic target region. However, ITet injection caused no structural change in striatal cells and nerve terminals in the mutants. These data indicate that ITet acts on striatal neurons bearing human IL-2Ralpha and temporally reduces their VAMP-2 content, thereby causing the blockade of transmitter release. Our ITet technology provides a useful approach for inducible and reversible control of synaptic transmission in specific neuronal types in the brain.

Indexed as

Analysis of VarianceAnimalsAntibodiesBehavior, AnimalChromatography, High Pressure LiquidCorpus StriatumFunctional Lateralitygamma-Aminobutyric AcidHumansInterleukin-2 Receptor alpha SubunitMiceMice, TransgenicNeuronsNeurotransmitter AgentsPotassium ChlorideReceptors, Dopamine D2Antibodiesgamma-Aminobutyric AcidInterleukin-2 Receptor alpha SubunitNeurotransmitter AgentsPotassium ChlorideReceptors, Dopamine D2Recombinant Fusion ProteinsTetanus ToxinVesicle-Associated Membrane Protein 2

Identifiers

PMID18775748
PMCPMC2591090
OpenAlexW1978411943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.